Psykedeelit (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Psykedeelit" in Finnish language version.

refsWebsite

Global rank Finnish rank

11nih.gov

4^th place

12^th place

5worldcat.org

5^th place

9^th place

4doi.org

2^nd place

10^th place

2theguardian.com

12^th place

22^nd place

2duodecimlehti.fi

low place

109^th place

1theatlantic.com

228^th place

583^rd place

1csp.org

low place

1web.archive.org

1^st place

1eb.com

5,420^th place

221^st place

1americanheadachesociety.org

low place

1ck-wissen.de

low place

1livescience.com

1,190^th place

469^th place

1maps.org

low place

5,059^th place

1nature.com

234^th place

201^st place

1reason.com

2,186^th place

4,821^st place

1tripsafe.org

low place

1psychologytoday.com

1,544^th place

421^st place

1ess.fi

low place

153^rd place

1hs.fi

647^th place

3^rd place

1psychedelictimes.com

low place

1paihdelinkki.fi

low place

535^th place

americanheadachesociety.org

Halpern JH, Passie T, Huertas PE, Karst M.: Attack cessation and remission induction with 2-bromo-LSD for cluster headache. Abstracts for the 14th Congress of the International Headache Society, 10–13 September 2009, Philadelphia, PA, USA. Cephalalgia. Oct. 2009; 29(Suppl. 1): P088 p. 46. DOI Free Abstract (PDF)^{[vanhentunut linkki]} IHS-IHC-2009 Poster Presentation Dr. John Halpern (PDF)

ck-wissen.de

Halpern JH, Passie T, Huertas PE, Karst M.: Attack cessation and remission induction with 2-bromo-LSD for cluster headache. Abstracts for the 14th Congress of the International Headache Society, 10–13 September 2009, Philadelphia, PA, USA. Cephalalgia. Oct. 2009; 29(Suppl. 1): P088 p. 46. DOI Free Abstract (PDF)^{[vanhentunut linkki]} IHS-IHC-2009 Poster Presentation Dr. John Halpern (PDF)

csp.org

MW Johnson, WA Richards, RR Griffiths: Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology, 1. heinäkuuta 2008, s. 2. Artikkelin verkkoversio. (englanniksi) (Arkistoitu – Internet Archive)

doi.org

dx.doi.org

Ede Frecska, Petra Bokor, Michael Winkelman: The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Frontiers in Pharmacology, 2.3.2016, nro 7. PubMed:26973523 doi:10.3389/fphar.2016.00035 ISSN 1663-9812 Artikkelin verkkoversio.
Yasushi Nakatani, Ikuko Sato-Suzuki, Naohisa Tsujino, Akane Nakasato, Yoshinari Seki, Masaki Fumoto: Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat. The European Journal of Neuroscience, May 2008, nro 9, s. 2466–2472. PubMed:18445233 doi:10.1111/j.1460-9568.2008.06201.x ISSN 1460-9568 Artikkelin verkkoversio.
David E. Nichols: Psychedelics. Pharmacological Reviews, 2016-4, nro 2, s. 264–355. PubMed:26841800 doi:10.1124/pr.115.011478 ISSN 0031-6997 Artikkelin verkkoversio.
Halpern JH, Passie T, Huertas PE, Karst M.: Attack cessation and remission induction with 2-bromo-LSD for cluster headache. Abstracts for the 14th Congress of the International Headache Society, 10–13 September 2009, Philadelphia, PA, USA. Cephalalgia. Oct. 2009; 29(Suppl. 1): P088 p. 46. DOI Free Abstract (PDF)^{[vanhentunut linkki]} IHS-IHC-2009 Poster Presentation Dr. John Halpern (PDF)

duodecimlehti.fi

Elina Hynninen, Rafael Moliner, Jesper Ekelund, Esa R. Korpi ja Lauri Elsilä: Psykedeelien kliiniset mahdollisuudet ja biologiset mekanismit. Lääketieteellinen aikakauskirja Duodecim, 2020, 136. vsk, nro 13, s. 1531-9. Artikkelin verkkoversio.
Erkki Isometsä: Onko huumeesta hoidoksi? Lääketieteellinen aikakauskirja Duodecim, 2020, 136. vsk, nro 13, s. 1511-3. Artikkelin verkkoversio.

eb.com

academic.eb.com

LSD, Encyclopaedia Britannica, 13.10.2015

ess.fi

Psykedeeleistä toivotaan lääkkeitä masennukseen, mutta aineiden tutkimus on vielä hyvin vähäistä ja osittain puutteellista Etelä-Suomen Sanomat. 16.7.2023.

hs.fi

Jani Kaaro: Tutkimus: Psykedeelisillä aineilla ei yhteyttä mielenterveysongelmiin Helsingin Sanomat. 19.8.2013. Viitattu 14.3.2017.

livescience.com

Tia Ghose: Short Trip? More People 'Microdosing' on Psychedelic Drugs Live Science. 8.7.2015. Viitattu 15.10.2015.

maps.org

Research, Multidisciplinary Association for Psychedelic Studies (MAPS)

nature.com

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first Nature. 30.6.2023.

nih.gov

ncbi.nlm.nih.gov

Franz X. Vollenweider: Brain mechanisms of hallucinogens and entactogens. Dialogues in Clinical Neuroscience, 2001-12, nro 4, s. 265–279. PubMed:22033605 ISSN 1294-8322 Artikkelin verkkoversio.
Ishier Raote, Aditi Bhattacharya, Mitradas M. Panicker: Serotonin Receptors in Neurobiology. Boca Raton (FL): CRC Press/Taylor & Francis, 2007. Virhe: Virheellinen ISBN-tunniste Teoksen verkkoversio (viitattu 5.12.2017).
Ede Frecska, Petra Bokor, Michael Winkelman: The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Frontiers in Pharmacology, 2.3.2016, nro 7. PubMed:26973523 doi:10.3389/fphar.2016.00035 ISSN 1663-9812 Artikkelin verkkoversio.
Yasushi Nakatani, Ikuko Sato-Suzuki, Naohisa Tsujino, Akane Nakasato, Yoshinari Seki, Masaki Fumoto: Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat. The European Journal of Neuroscience, May 2008, nro 9, s. 2466–2472. PubMed:18445233 doi:10.1111/j.1460-9568.2008.06201.x ISSN 1460-9568 Artikkelin verkkoversio.
David E. Nichols: Psychedelics. Pharmacological Reviews, 2016-4, nro 2, s. 264–355. PubMed:26841800 doi:10.1124/pr.115.011478 ISSN 0031-6997 Artikkelin verkkoversio.
Paul L. Schiff: Ergot and Its Alkaloids. American Journal of Pharmaceutical Education, 15.10.2006, nro 5. PubMed:17149427 ISSN 0002-9459 Artikkelin verkkoversio.

pubmed.ncbi.nlm.nih.gov

Franz X. Vollenweider: Brain mechanisms of hallucinogens and entactogens. Dialogues in Clinical Neuroscience, 2001-12, nro 4, s. 265–279. PubMed:22033605 ISSN 1294-8322 Artikkelin verkkoversio.
Ede Frecska, Petra Bokor, Michael Winkelman: The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Frontiers in Pharmacology, 2.3.2016, nro 7. PubMed:26973523 doi:10.3389/fphar.2016.00035 ISSN 1663-9812 Artikkelin verkkoversio.
Yasushi Nakatani, Ikuko Sato-Suzuki, Naohisa Tsujino, Akane Nakasato, Yoshinari Seki, Masaki Fumoto: Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat. The European Journal of Neuroscience, May 2008, nro 9, s. 2466–2472. PubMed:18445233 doi:10.1111/j.1460-9568.2008.06201.x ISSN 1460-9568 Artikkelin verkkoversio.
David E. Nichols: Psychedelics. Pharmacological Reviews, 2016-4, nro 2, s. 264–355. PubMed:26841800 doi:10.1124/pr.115.011478 ISSN 0031-6997 Artikkelin verkkoversio.
Paul L. Schiff: Ergot and Its Alkaloids. American Journal of Pharmaceutical Education, 15.10.2006, nro 5. PubMed:17149427 ISSN 0002-9459 Artikkelin verkkoversio.

paihdelinkki.fi

Sienet, Päihdelinkki

psychedelictimes.com

Wesley Thoricatha: What are the Dangers of Psychedelics? Things to Consider Before a Psychedelic Experience Psychedelic Times. 25.1.2016. Viitattu 14.3.2017.

psychologytoday.com

Scott A. McGreal: The Spirituality of Psychedelic Drug Users Psychology Today. 13.12.2012. Viitattu 14.3.2017.

reason.com

Pot Prohibition Continues Collapsing, and Psychedelic Bans Could Be Next Reason. 9.11.2022.

theatlantic.com

Richard J. Miller: Religion as a Product of Psychotropic Drug Use The Atlantic. 27.12.2013. Viitattu 13.3.2017.

theguardian.com

Mo Costandi: A brief history of psychedelic psychiatry The Guardian. 2.9.2014. Viitattu 13.3.2017.
Richard Vine: The secret LSD-fuelled CIA experiment that inspired Stranger Things The Guardian. 15.8.2016. Viitattu 13.3.2017.

tripsafe.org

guides.tripsafe.org

Johnson, M., Richards, W., & Griffiths, R.: Key excerpts from “Human hallucinogen research: guidelines for safety” (Johnson, Richards, & Griffiths, 2008) Journal of Psychopharmacology. 2008. Tripsafe.org. Viitattu 23.3.2017.^{[vanhentunut linkki]}

web.archive.org

MW Johnson, WA Richards, RR Griffiths: Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology, 1. heinäkuuta 2008, s. 2. Artikkelin verkkoversio. (englanniksi) (Arkistoitu – Internet Archive)

worldcat.org

Franz X. Vollenweider: Brain mechanisms of hallucinogens and entactogens. Dialogues in Clinical Neuroscience, 2001-12, nro 4, s. 265–279. PubMed:22033605 ISSN 1294-8322 Artikkelin verkkoversio.
Ede Frecska, Petra Bokor, Michael Winkelman: The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Frontiers in Pharmacology, 2.3.2016, nro 7. PubMed:26973523 doi:10.3389/fphar.2016.00035 ISSN 1663-9812 Artikkelin verkkoversio.
Yasushi Nakatani, Ikuko Sato-Suzuki, Naohisa Tsujino, Akane Nakasato, Yoshinari Seki, Masaki Fumoto: Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat. The European Journal of Neuroscience, May 2008, nro 9, s. 2466–2472. PubMed:18445233 doi:10.1111/j.1460-9568.2008.06201.x ISSN 1460-9568 Artikkelin verkkoversio.
David E. Nichols: Psychedelics. Pharmacological Reviews, 2016-4, nro 2, s. 264–355. PubMed:26841800 doi:10.1124/pr.115.011478 ISSN 0031-6997 Artikkelin verkkoversio.
Paul L. Schiff: Ergot and Its Alkaloids. American Journal of Pharmaceutical Education, 15.10.2006, nro 5. PubMed:17149427 ISSN 0002-9459 Artikkelin verkkoversio.